DISCONTINUED OPERATIONS - Narrative (Details) - USD ($) $ in Millions			1 Months Ended	12 Months Ended
	Jan. 31, 2025	Sep. 29, 2023	May 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Transaction service agreement, period			24 months
Book value		$ 840
Other comprehensive income				$ 183	$ 68	$ 223
Manufacturing and supply agreement, period			5 years
Kidney Care Manufacturing and Supply Agreement | Subsequent Event
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Transaction service agreement, period	10 years
Kidney Care Transition Services Agreement | Subsequent Event
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Transaction service agreement, period	30 months
Discontinued Operations, Disposed of by Sale | BioPharma Solutions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Agreed purchase price		4,250
Proceeds from divestiture of businesses		3,910
Pre-tax cash proceeds		3,960
Pre-tax gain on sale		2,880
Net proceeds of sale		2,590
Transaction costs		47
Other comprehensive income		$ 181
Separation costs				$ 261	17
Discontinued Operations, Disposed of by Sale | Kidney Care
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Separation costs					$ 196
Discontinued Operations, Disposed of by Sale | Kidney Care | Subsequent Event
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Agreed purchase price	$ 3,800
Proceeds from divestiture of businesses	3,710
Proceeds	$ 3,400